Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual–target platinum(IV) complexes reverse cisplatin resistance in triple negative breast via inhibiting poly(ADP–ribose) polymerase (PARP–1) and enhancing DNA damage
Rui Li, Weiheng Zhao, Jin Chen, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106354-106354
Closed Access | Times Cited: 11

Showing 11 citing articles:

Beyond cisplatin: New frontiers in metallodrugs for hard-to-treat triple negative breast cancer
Muhammad Nafees, Muhammad Hanif, Piaoping Yang
Coordination Chemistry Reviews (2023) Vol. 499, pp. 215507-215507
Closed Access | Times Cited: 26
Olaparib research update: mechanism, structure and clinical trials
Hao Che, Liwei Wang, Xiang‐Yang Ye, et al.
Medicinal Chemistry Research (2025)
Closed Access | Times Cited: 1
Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance
Meng Wang, Guimei Li, Guiyang Jiang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6218-6237
Closed Access | Times Cited: 8
Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity
Sainath Babaji Aher, J. Zhu, Pundlik Rambhau Bhagat, et al.
Topics in Current Chemistry (2024) Vol. 382, Iss. 1
Closed Access | Times Cited: 7
Glycyrrhetinic Acid as a Hepatocyte Targeting Ligand-Functionalized Platinum(IV) Complexes for Hepatocellular Carcinoma Therapy and Overcoming Multidrug Resistance
Xiaochao Huang, Guimei Li, Huifang Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 8020-8042
Closed Access | Times Cited: 6
Discovery of a Novel EF24 Analogue-Conjugated Pt(IV) Complex as Multi-Target Pt(IV) Prodrugs Aims to Enhance Anticancer Activity and Overcome Cisplatin Resistance
Meng Wang, Guimei Li, Nan Xu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Pt(IV)-PROTAC Complexes with Synergistic Antitumor Activity and Enhanced Membrane Permeability
Chang‐Jiu Li, Z. Q. Zou, Shan Xu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium Compound
Nazia Nayeem, Sami Sauma, Afruja Ahad, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 5, pp. 1364-1376
Closed Access | Times Cited: 2
Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action
Daniil Spector, Anna Bubley, Елена К. Белоглазкина, et al.
Russian Chemical Reviews (2023) Vol. 92, Iss. 10, pp. RCR5096-RCR5096
Closed Access | Times Cited: 5
Theoretical Studies Revealing Mitochondrial-Targeted Anticancer Activity of Oxovanadium (V) Complexes

Letters in Applied NanoBioScience (2024) Vol. 13, Iss. 4, pp. 174-174
Open Access
Theoretical Description for Psilocin and Coprine Electrochemical Determination in Mushroom Pulp and Biological Liquids over Cobalt (II) Oxyhydroxide-Modified Electrode

Letters in Applied NanoBioScience (2024) Vol. 13, Iss. 4, pp. 173-173
Open Access
Page 1

Scroll to top